🇺🇸 FDA
Patent

US 12059474

Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins

granted A61KA61K47/6803A61K47/68031

Quick answer

US patent 12059474 (Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins) held by The Board of Regents of the University of Texas System expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K47/6803, A61K47/68031, A61K47/6849, A61K47/6855